Clinical Trial Update: NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization [Phase 4]

View source ↗

Summary

Phase 4 trial comparing N-acetylcysteine versus ascorbic acid to prevent contrast-induced nephropathy in patients with renal insufficiency undergoing coronary c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Contrast-induced Nephropathy

Drugs mentioned

• Ascorbic acid (Vitamin C)
• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Kidney Failure | Phase 4 | Status: COMPLETED